Edition:
United States

Quidel Corp (QDEL.OQ)

QDEL.OQ on NASDAQ Stock Exchange Global Select Market

27.16USD
4:00pm EDT
Change (% chg)

$-0.17 (-0.62%)
Prev Close
$27.33
Open
$27.33
Day's High
$27.65
Day's Low
$27.13
Volume
45,533
Avg. Vol
65,428
52-wk High
$27.75
52-wk Low
$16.64

QDEL.OQ

Chart for QDEL.OQ

About

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in... (more)

Overall

Beta: 1.25
Market Cap(Mil.): $907.52
Shares Outstanding(Mil.): 33.21
Dividend: --
Yield (%): --

Financials

  QDEL.OQ Industry Sector
P/E (TTM): 266.37 39.14 19.11
EPS (TTM): 0.10 -- --
ROI: 1.08 8.76 -5.00
ROE: 1.88 13.54 -4.24

BRIEF-Quidel receives the CE mark for its thyretain tbi reporter bioassay

* Quidel receives the CE mark for its thyretain® tbi reporter bioassay Source text for Eikon: Further company coverage:

Jun 07 2017

BRIEF-Quidel gets FDA clearance, CLIA waiver for Sofia 2 Immunoassay analyzer

* Quidel receives FDA clearance and CLIA waiver for its point-of-care Sofia 2 Immunoassay analyzer for use with Sofia Influenza A+B Assay Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

May 30 2017

BRIEF-Quidel receives PMDA approval for its point-of-care SOFIA Influenza A+B Assay

* Quidel receives PMDA approval for its point-of-care Sofia Influenza A+B Assay

May 24 2017

BRIEF-Quidel receives FDA clearance for Solana(R) molecular assay for detecting C. difficile infections

* Quidel receives FDA clearance for its new Solana(R) molecular assay for the detection of Clostridium difficile (C. difficile) infections

May 11 2017

BRIEF-Quidel reports Q1 earnings per share $0.42

* Q1 earnings per share view $0.14 -- Thomson Reuters I/B/E/S

Apr 24 2017

BRIEF-Quidel reports Q4 gaap loss per share $0.06

* Quidel reports fourth quarter and full year 2016 financial results

Feb 08 2017

More From Around the Web

Competitors

Earnings vs. Estimates